Prenatal buprenorphine exposure decreases neurogenesis in rats

Toxicology Letters

Volumn 225, Issue 1, 2014, Pages 92-101

  Wu, Chih Cheng ^a,b   Hung, Chih Jen ^a,c   Shen, Ching Hui ^a   Chen, Wen Ying ^d   Chang, Cheng Yi ^e   Pan, Hung Chuan ^a,f   Liao, Su Lan ^a   Chen, Chun Jung ^a,c,d,g  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b PROVIDENCE UNIVERSITY   (Taiwan)

^c HUNGKUANG UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e FENG YUAN HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Depression; Neurogenesis; Neurotrophin; Opioid

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUPRENORPHINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOUBLECORTIN; KRUPPEL LIKE FACTOR 4; NESTIN; RECEPTOR; TRANSCRIPTION FACTOR SOX2; TROPOMYOSIN; TROPOMYOSIN RELATED KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; COGNITION; DEPRESSION; ENZYME ACTIVITY; FEMALE; FORCED SWIM TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TAIL SUSPENSION TEST; WESTERN BLOTTING;

DEPRESSION; NEUROGENESIS; NEUROTROPHIN; OPIOID;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUPRENORPHINE; CELL PROLIFERATION; CELLS, CULTURED; CREB-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GESTATIONAL AGE; INJECTIONS, INTRAPERITONEAL; MALE; MATERNAL EXPOSURE; MOTOR ACTIVITY; NERVOUS SYSTEM; NEUROGENESIS; NEURONS; PHOSPHORYLATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKB; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; SWIMMING; TIME FACTORS;

EID: 84890847240     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.12.001     Document Type: Article

References (52)

1. Alto W.A., O'Connor A.B. Management of women treated with buprenorphine during pregnancy. Am. J. Obstet. Gynecol. 2011, 205:302-308.
2. Anacker C., Zunszain P.A., Cattaneo A., Carvalho L.A., Garabedian M.J., Thuret S., Price J., Pariante C.M. Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol. Psychiatry 2011, 16:738-750.
3. Arguello A.A., Fischer S.J., Schonborn J.R., Markus R.W., Brekken R.A., Eisch A.J. Effect of chronic morphine on the dentate gyrus neurogenic microenvironment. Neuroscience 2009, 159:1003-1010.
4. Bhatia H.S., Agrawal R., Sharma S., Huo Y.X., Ying Z., Gomez-Pinilla F. Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PLoS ONE 2011, 6:e28451.
5. Blandthorn J., Forster D.A., Love V. Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit. Women Birth 2011, 24:32-39.
6. Bruijnzeel A.W., Bauzo R.M., Munikoti V., Rodrick G.B., Yamada H., Fornal C.A., Ormerod B.K., Jacobs B.L. Tobacco smoke diminishes neurogenesis and promotes gliogenesis in the dentate gyrus of adolescent rats. Brain Res. 2011, 1412:32-42.
7. Bryant H.U., Bemton E.W., Kenner J.R., Holaday J.W. Role of adrenal cortical activation in the immunosuppressive effects of chronic morphine treatment. Endocrinology 1991, 128:3253-3258.
8. Coe C.L., Kramer M., Czéh B., Gould E., Reeves A.J., Kirschbaum C., Fuchs E. Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol. Psychiatry 2003, 54:1025-1034.
9. Compton W.M., Volkow N.D. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006, 83:S4-S7.
10. Coyle M.G., Salisbury A.L., Lester B.M., Jones H.E., Lin H., Graf-Rohrmeister K., Fischer G. Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Addiction 2012, 107:63-73.
11. Dranovsky A., Hen R. Hippocampal neurogenesis: regulation by stress and antidepressants. Biol. Psychiatry 2006, 59:1136-1143.
12. Dwivedi Y., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. [(3)H]cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims. Am. J. Psychiatry 2002, 159:66-73.
13. Dwivedi Y., Pandey G.N. Adenylyl cyclase-cyclicAMP signaling in mood disorders: role of the crucial phosphorylating enzyme protein kinase A. Neuropsychiatr. Dis. Treat. 2008, 4:161-176.
14. Eisch A.J., Barrot M., Schad C.A., Self D.W., Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:7579-7584.
15. Engelberger W., Kögel B., Friderichs E., Straburger W., Germann T. Reversibility of opioid receptor occupancy of buprenorphine in vivo. Eur. J. Pharmacol. 2006, 534:95-102.
16. Farid W.O., Dunlop S.A., Tait R.J., Hulse G.K. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr. Neuropharmacol. 2008, 6:125-150.
17. Fischer G., Ortner R., Rohrmeister K., Jagsch R., Baewert A., Langer M., Aschauer H. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006, 101:275-281.
18. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
19. Givalois L., Arancibia S., Alonso G., Tapia-Arancibia L. Expression of brain-derived neurotrophic factor in the rat median eminence cells with sensitivity to stress. Endocrinology 2004, 145:4737-4747.
20. Gould E. How widespread is adult neurogenesis in mammals?. Nat. Rev. Neurosci. 2007, 8:481-488.
21. Guzmán D.C., Vázquez I.E., Brizuela N.O., Alvarez R.G., Mejía G.B., García E.H., Santamaria D., de Apreza M.R., Olguin H.J. Assessment of oxidative damage induced by acute doses of morphine sulfate in postnatal and adult rat brains. Neurochem. Res. 2006, 31:549-554.
22. Hall T.J., Jagher B., Schaeublin M., Wiesenberg I. The analgesic drug buprenorphine inhibits osteoclastic bone resorption in vitro, but is proinflammatory in rat adjuvant arthritis. Inflamm. Res. 1996, 45:299-302.
23. Hanson N.D., Owens M.J., Nemeroff C.B. Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology 2011, 36:2589-2602.
24. Jansson L.M., DiPietro J.A., Velez M., Elko A., Williams E., Milio L., O'Grady K., Jones H.E. Fetal neurobehavioral effects of exposure to methadone or buprenorphine. Neurotoxicol. Teratol. 2011, 33:240-243.
25. Jarvis M.A.E., Schnoll S.H. Methadone treatment during pregnancy. J. Psychoactive Drugs 1994, 26:155-161.
26. Kakko J., Hellig M., Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend. 2008, 96:69-78.
27. Katakura M., Hashimoto M., Shahdat H.M. Docosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cells. Neuroscience 2009, 160:651-660.
28. Kim J.E., Ji E.S., Seo J.H., Lee M.H., Cho S., Park Y.K., Seo T.B., Kim C.J. Alcohol exposure induces depression-like behavior by decreasing hippocampal neuronal proliferation through inhibition of the BDNF-ERK pathway in gerbils. Anim. Cells Syst. 2012, 16:190-197.
29. Klempin F., Beis D., Mosienko V., Kempermann G., Bader M., Alenina N. Serotonin is required for exercise-induced adult hippocampal neurogenesis. J. Neurosci. 2013, 33:8270-8275.
30. Kuhn H.G., Blomgren K. Developmental dysregulation of adult neurogenesis. Eur. J. Neurosci. 2011, 33:1115-1122.
31. Lejeune C., Simmat-Durand L., Gourarier L., Aubisson S. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high dose buprenorphine substitution. Drug Alcohol Depend. 2006, 82:250-257.
32. Li J., Geng D., Xu J., Weng L.J., Liu Q., Yi L.T. Antidepressant-like effect of macranthol isolated from Illicium dunnianum tutch in mice. Eur. J. Pharmacol. 2013, 707:112-119.
33. Liebenberg N., Müller H.K., Fischer C.W., Harvey B.H., Brink C.B., Elfving B., Wegener G. An inhibitor of cAMP-dependent protein kinase induces behavioral and neurological antidepressant-like effects in rats. Neurosci. Lett. 2011, 498:158-161.
34. Lund I.O., Fisher G., Welle-Strand G.K., O'Grady K.E., Debelak K., Morrone W.R., Jones H.E. A comparison of buprenorphine+naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes. Subst. Abuse 2013, 7:61-74.
35. Malanga C.J., Kosofsky B.E. Mechanisms of action of drugs of abuse on the developing fetal brain. Clin. Perinatol. 1999, 26:17-37.
36. Markó K., Köhidi T., Hádinger N., Jelitai M., Mezö G., Madarász E. Isolation of radial glial-like neural stem cells from fetal and adult mouse forebrain via selective adhesion to a novel adhesive peptide-conjugate. PLoS ONE 2011, 6:e28538.
37. Marquez P., Baliram R., Kieffer B.L., Lutfy K. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference. Neuropharmacology 2007, 52:1336-1341.
38. Ohta S., Gregg C., Weiss S. Pituitary adenylate cyclase-activating polypeptide regulates forebrain neural stem cells and neurogenesis in vitro and in vivo. J. Neurosci. Res. 2006, 84:1177-1186.
39. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Roberts R.C., Conley R.R. Cyclic AMP response element-binding protein in postmortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int. J. Neuropsychopharmacol. 2007, 10:621-629.
40. Pettit A.S., DesRoches R., Bennett S.A.L. The opiate analgesic buprenorphine decreases proliferation of adult hippocampal neuroblasts and increases survival of their progeny. Neuroscience 2012, 200:211-222.
41. Reece A.S., Davidson P. Deficit of circulating stem-progenitor cells in opiate addiction: a pilot study. Subst. Abuse Treat. Prev. Policy 2007, 2:19.
42. Réus G.Z., Stringari R.B., Ribeiro K.F., Ferraro A.K., Vitto M.F., Cesconetto P., Souza C.T., Quevedo J. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav. Brain Res. 2011, 221:166-171.
43. Robinson S.E. Effects of buprenorphine and methadone exposures on striatal cholinergic ontogeny. Neurotoxicol. Teratol. 2002, 24:137-142.
44. Rounsaville B., Weissman M., Crits-Christoph K., Wilber C., Kleber H. Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment outcome. Arch. Gen. Psychiatry 1982, 39:151-156.
45. Sanchez E.S., Bigbee J.W., Fobbs W., Robinson S.E., Sato-Bigbee C. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia 2008, 56:1017-1027.
46. Seidler F.J., Whitmore W.L., Slotkin T.A. Delays in growth and biochemical development of rat brain caused by maternal methadone administration: are there alterations in synaptogenesis and cellular maturation independent of reduced maternal food intake?. Dev. Neurosci. 1982, 5:13-18.
47. Shin M.S., Ko I.G., Kim S.E., Kim B.K., Kim T.S., Lee S.H., Hwang D.S., Kim C.J., Park J.K., Lim B.V. Treadmill exercise ameliorates symptoms of methimazole-induced hypothyroidism through enhancing neurogenesis and suppressing apoptosis in the hippocampus of rat pups. Int. J. Dev. Neurosci. 2013, 31:214-223.
48. Vallieres L., Campbell I.L., Gage F.H., Sawchenko P.E. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 2002, 22:486-492.
49. Velez M., Jansson L.M., Schroeder J., Williams E. Prenatal methadone exposure and neonatal neurobehavioral functioning. Pediatr. Res. 2009, 66:704-709.
50. Walsh S.L., Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003, 70.:S13-S27.
51. Wu V.W., Mo Q., Yabe T., Schwartz J.P., Robinson S.E. Perinatal opioids reduce striatal nerve growth factor content in rat striatum. Eur. J. Pharmacol. 2001, 414:211-214.
52. Xuan A., Long D., Li J., Ji W., Hong L., Zhang M., Zhang W. Neuroprotective effects of valproic acid following transient global ischemia in rats. Life Sci. 2012, 90:463-468.